TCS whitepaper

Reimagining the Clinical Trials Process through Digital Disruption

Conventional clinical trial processes require significant time and resources to be invested for data cleaning, monitoring, and reporting to the concerned regulatory authorities. This directly influences the cost of the trial, and thus the time to market. Explore how digitization of clinical trial processes can help transform the clinical research industry. The clinical trials industry manages large volumes of patient data …

Statistics show increase in clinical trials in emerging markets

Latin America, Central and Eastern Europe (CEE) and parts of Asia are often classified as ‘emerging markets' within the pharmaceutical sector. Recent years have seen huge growth in pharmaceutical operations within these regions – more R&D, more manufacturing, more outsourcing service providers and more partnering/M&A opportunities. As is depicted below, the number of clinical trials initiated in the CEE region …

Pharma and Biotech Speaker Opportunities at BioPharma CEE Convention 2013

The  BioPharma CEE Convention, taking place from 28-29 May in Budapest in 2013 is looking for Global and Local CEE Clinical and Manufacture Heads of Pharma and Biotech to deliver case study presentations or sit on panels at this exclusive event. The event is positioned as the region's obvious choice of a scientific and commercial congress for senior executives from …

Download: eBook – 10 Key Insights into Clinical Trials in Central and Eastern Europe

Did you know there are statistically lower amount of adverse findings in FDA inspections conducted in Central and Eastern Europe (CEE) than in Western Europe?   Outside of the obvious BRIC countries, many pharmaceutical companies are now turning towards the CEE region as an alternative region in which to locate their clinical trials. As with any emerging market, CEE offers …

10 things we’ve learnt about the biopharma industry in CEE

We've been undertaking some research with those who work in the biopharma industry in Central and Eastern Europe (CEE), to better understand their businesses, challenges and concerns. Here is a selection of some of the key points that our research uncovered. 1. For those operating in CEE, the highest interest at present is in Hungary, closely followed by the Czech …

5 Challenges of Operating Clinical Trials in CEE

Central and Eastern Europe (CEE) is a current hotspot for clinical trial operations. There are many factors that make this region an attractive site for clinical trials, but there are some challenges to overcome too. We've been talking to experts in the region to uncover the difficulties they face. 1. Complex regulatory systems Each CEE country has different processes and …

5 Advantages of Operating Clinical Trials in CEE

Central and Eastern Europe (CEE) is a current hotspot for clinical trial operations. There are many factors that make this region an attractive site for clinical trials. We've been talking to experts in CEE to uncover what the key advantages of this region are. 1. Large pool of treatment-naive patients The CEE region has over 300 million inhabitants, many of …